System and method for providing alerts optimized for a user

Patent metadata

Field	Value
Publication number	US-11837348-B2
Application number	US-202217933197-A
Country	US
Kind code	B2
Filing date	Sep 19, 2022
Priority date	May 2, 2016
Publication date	Dec 5, 2023
Grant date	Dec 5, 2023

Abstract

Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

First claim

What is claimed is:

1. A non-transitory computer readable medium, comprising instructions for causing a computing system to perform a method of alerting a user of an infusion system about an infusion system event warranting user attention, the method comprising:
receiving continuous analyte monitoring data from a continuous analyte monitor of the user;
receiving medicament delivery device data from a medicament delivery device of the infusion system;
identifying the infusion system event, based at least partially on the medicament delivery device data, the continuous analyte monitoring data, and a comparison of the medicament delivery device data to patterns of historical medicament delivery device data;
determining if the user is cognitively aware of the infusion system event; and
alerting the user, through a user interface of the computing system, of the infusion system event if the user is not cognitively aware of the infusion system event.

2. The non-transitory computer readable medium of claim 1 , wherein the medicament delivery device data comprises one or more of bolus data, medicament delivery device shutoff data, medicament delivery device alarm data, medicament delivery device rewind time data, medicament delivery device prime data, cannula fill data, reservoir change data, and medicament delivery device fluid pressure data.

3. The non-transitory computer readable medium of claim 1 , wherein determining if the user is cognitively aware of the identified infusion system event comprises:
determining, based on the medicament delivery device data, that at least a portion of the infusion system of the user is being replaced or has been replaced.

4. The non-transitory computer readable medium of claim 1 , wherein the infusion system event corresponds to an infusion site or a cannula that does not properly absorb insulin.

5. The non-transitory computer readable medium of claim 1 , wherein the infusion system event corresponds to an occluded infusion site or a cannula.

6. The non-transitory computer readable medium of claim 1 , wherein the patterns of historical medicament delivery device data are indicative of issues preventing proper operation of the medicament delivery device.

7. The non-transitory computer readable medium of claim 1 , wherein determining if the user is cognitively aware of the identified infusion system event comprises one or more of:
determining if the user has previously treated a similar identified infusion system by taking an action without receiving a user prompt;
determining if a user behavior is consistent with cognitive awareness of the identified infusion system event; or
identifying one or more user inputs indicative of cognitive awareness of the identified infusion system event.

8. A computing system, comprising:
a memory comprising executable instructions;
a processor in data communication with the memory and configured to execute the instructions to:
receive continuous analyte monitoring data from a continuous analyte monitor of a user;
receive medicament delivery device data from a medicament delivery device of an infusion system of the user;
identify an infusion system event, based at least partially on the medicament delivery device data, the continuous analyte monitoring data, and a comparison of the medicament delivery device data to patterns of historical medicament delivery device data;
determine if the user is cognitively aware of the infusion system event; and
alert the user, via a user interface of the computing system, of the infusion system event if the user is not cognitively aware of the infusion system event.

9. The computing system of claim 8 , wherein the medicament delivery device data comprises one or more of bolus data, medicament delivery device shutoff data, medicament delivery device alarm data, medicament delivery device rewind time data, medicament delivery device prime data, cannula fill data, reservoir change data, and medicament delivery device fluid pressure data.

10. The computing system of claim 8 , wherein the processor being configured to determine if the user is cognitively aware of the identified infusion system event comprises:
the processor being configured to determine, based on the medicament delivery device data, that at least a portion of the infusion system of the user is being replaced or has been replaced.

11. The computing system of claim 8 , wherein the infusion system event corresponds to an infusion site or a cannula that does not properly absorb insulin.

12. The computing system of claim 8 , wherein the infusion system event corresponds to an occluded infusion site or a cannula.

13. The computing system of claim 8 , wherein the patterns of historical medicament delivery device data are indicative of issues preventing proper operation of the medicament delivery device.

14. The computing system of claim 8 , wherein the processor being configured to determine if the user is cognitively aware of the identified infusion system event comprises one or more of the processor being configured to:
determine if the user has previously treated a similar identified infusion system by taking an action without receiving a user prompt;
determine if a user behavior is consistent with cognitive awareness of the identified infusion system event; or
identify one or more user inputs indicative of cognitive awareness of the identified infusion system event.

15. A method of alerting a user of an infusion system about an infusion system event warranting attention, the method comprising:
receiving continuous analyte monitoring data from a continuous analyte monitor of the user;
receiving medicament delivery device data from a medicament delivery device of the infusion system;
identifying the infusion system event, based at least partially on the medicament delivery device data, the continuous analyte monitoring data, and a comparison of the medicament delivery device data to patterns of historical medicament delivery device data;
determining if the user is cognitively aware of the infusion system event; and
alerting the user, through a user interface of a computing system, of the infusion system event if the user is not cognitively aware of the infusion system event.

16. The method of claim 15 , wherein the medicament delivery device data comprises one or more of bolus data, medicament delivery device shutoff data, medicament delivery device alarm data, medicament delivery device rewind time data, medicament delivery device prime data, cannula fill data, reservoir change data, and medicament delivery device fluid pressure data.

17. The method of claim 15 , wherein determining if the user is cognitively aware of the identified infusion system event comprises:
determining, based on the medicament delivery device data, that at least a portion of the infusion system of the user is being replaced or has been replaced.

18. The method of claim 15 , wherein the infusion system event corresponds to an infusion site or a cannula that does not properly absorb insulin.

19. The method of claim 15 , wherein the patterns of historical medicament delivery device data are indicative of issues preventing proper operation of the medicament delivery device.

20. The method of claim 15 , wherein determining if the user is cognitively aware of the identified infusion system event comprises one or more of:
determining if the user has previously treated a similar identified infusion system by taking an action without receiving a user prompt;
determi

Assignees

• Dexcom Inc

Inventors

• Davis Anna Leigh
• Belliveau Scott M
• Bhavaraju Naresh C
• Bowman Leif N
• Castillo Rita M
• Constantin Alexandra Elena
• Draeger Rian W
• Dunn Laura J
• Gable Gary Brian
• Garcia Arturo
• Hall Thomas
• Hampapuram Hari
• Hannemann Christopher Robert
• Harley-Trochimczyk Anna Claire
• Heintzman Nathaniel David
• Jackson Andrea Jean
• Jepson Lauren Hruby
• Kamath Apurv Ullas
• Koehler Katherine Yerre
• Mandapaka Aditya Sagar
• Marsh Samuel Jere
• Morris Gary A
• Pai Subrai Girish
• Pal Andrew Attila
• Polytaridis Nicholas
• Pupa Philip Thomas
• Reihman Eli
• Rindfleisch Ashley Anne
• Schunk Sofie Wells
• Simpson Peter C
• Smith Daniel S
• Vanslyke Stephen J
• Vogel Matthew T
• Walker Tomas C
• West Benjamin Elrod
• Wiley Atiim Joseph

Classifications

• G16H20/17 Primary

  delivered via infusion or injection · CPC title

• A61B5/0022

  Monitoring a patient using a global network, e.g. telephone networks, internet · CPC title

• A61B5/024

  Measuring pulse rate or heart rate · CPC title

• A61B5/1112

  Global tracking of patients, e.g. by using GPS · CPC title

• A61B5/14517

  for sweat · CPC title